Join to view full profile
4500 Forest Park AveDiv IM Bone Marrow Transplant 5TH 6TH 8TH FLSt. Louis, MO 63108
Phone+1 314-454-8304
Fax+1 314-454-5902
Dr. Dipersio is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1984 - 1985
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1980 - 1984
University of Rochester School of Medicine and DentistryClass of 1980
Certifications & Licensure
CA State Medical License 1984 - Present
IL State Medical License 2021 - 2029
MO State Medical License 1994 - 2027
NY State Medical License 1990 - 1994
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR (Modular), Allscripts, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification Follow My Health, Jardogs, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR, Allscripts, 2013-2014, 2016-2017
Clinical Trials
Publications & Presentations
PubMed
- Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome Following Axicabtagene Ciloleucel or Brexucabtagene Autoleucel Chimeric Antigen Re...Matthew J Frigault, Richard T Maziarz, Theresa Amoloja, Lea Burke, Valkal Bhatt
Transplantation and Cellular Therapy. 2026-07-31 - NT-I7, a Long-Acting Interleukin 7, Increases Lymphocyte Counts and Induces CD8+ T-cell Clonotype Expansion in Patients with Newly Diagnosed High-Grade Gliomas.Omar H Butt, Kartik Singhal, Jingqin Luo, Michael P Rettig, Jennifer A Foltz
Clinical Cancer Research. 2026-07-01 - 2 citationsBase Editing ofandPromoters for Sickle Cell Disease.Ashish O Gupta, Akshay Sharma, Haydar Frangoul, Julie Kanter, Markus Y Mapara
The New England Journal of Medicine. 2026-05-07
Journal Articles
- Secondary Acute Lymphoblastic Leukemia, a Retrospective Analysis from Washington University and Meta-Analysis of Published DataFrancesca Ferraro, Peter Westervelt, John F Dipersio, Armin Ghobadi, Leukemia Research
- Secondary Acute Lymphoblastic Leukemia, a Retrospective Analysis from Washington University and Meta-Analysis of Published DataFrancesca Ferraro, Peter Westervelt, John F Dipersio, Armin Ghobadi, Leukemia Research
- Single Institution Experience with G-CSF Mobilized T-cell Replete Haploidentical Hematopoietic Cell TransplantationM A Schroeder, R Romee, J F DiPersio, T A Fehniger, F Gao, G L Uy, C N Abboud, P Westervelt, R Vij, Nature
Abstracts/Posters
- CXCR4 Inhibition with BL-8040 in Combination with Nelarabine in Patients with Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia / Lymphoblastic LymphomaJohn F. DiPersio, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Increased Early Mortality after Fludarabine and Melphalan Conditioning with Peripheral Blood Grafts in Haploidentical SCT with Post-Transplant CyclophosphamideJohn F. DiPersio, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Single-Cell Pathway Enrichment and Regulatory Profiling of Multiple Myeloma across Disease StagesJohn F. DiPersio, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Rapid and Robust Mobilization of CD34+ HSCs without G-CSF Following Administration of Mgta-145 Alone or in Combination with Plerixafor61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- A Long-Acting Pharmacological Grade Interleukin-7 Molecule Logarithmically Accelerates Ucart Proliferation, Differentiation, and Tumor Killing2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Conditioning for Hematopoietic Stem Cell Transplantation Using Antibody-Drug Conjugate Targeting CD45 Permits Engraftment across Immunologic Barriers2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Authored Content
- Secondary Acute Lymphoblastic Leukemia, a Retrospective Analysis from Washington University and Meta-Analysis of Published DataAugust 2018
Press Mentions
Gene Therapy Treatment for Sickle Cell Disease Changes Lives in St. LouisJune 9th, 2026
WashU Startups Attract Record-Setting $1.7 Billion in Private-Sector Investment Over Past YearJanuary 6th, 2026
Early-Career Physician-Scientists Receive Major Support from Damon Runyon Cancer Research FoundationJuly 13th, 2025
Grant Support
- Optimizing Hematopoietic Stem Cell Transplantation For The Treatment Of Hematological MalignanciesWASHINGTON UNIVERSITY2017–2032
- Optimizing Hematopoietic Stem Cell Transplantation For The Treatment Of Hematological MalignanciesWASHINGTON UNIVERSITY2017–2032
- Washington University Paul Calabresi K12 Career Development Award for Clinical OncologyWASHINGTON UNIVERSITY2012–2027
- Targeting Aml-Stromal InteractionsNational Cancer Institute2011–2012
- Genomics Of Acute Myelogenous Leukemia (Aml): Relapse And Resistance FactorsNational Cancer Institute2008–2012
Professional Memberships
- Member
- Fellow
- Member
- American Society of Blood and Marrow TransplantationVice President
- Board of Scientific Councilors, National Cancer InstituteMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:










